We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Menopause Can Increase Risk of Metabolic Syndrome

By HospiMedica International staff writers
Posted on 14 Jul 2020
A new study identifies menopause as a risk factor for the development of metabolic syndrome (MTS) or its components, such as hypertension and high blood sugar.

Researchers at St. Michael’s Hospital (Toronto, Canada), the University of Toronto (Canada), and other institutions conducted a cross-sectional analysis of 12,611 women (45 to 85 years of age) who participated in the Canadian Longitudinal Study on Aging Comprehensive Cohort in order to evaluate menopause as an independent risk factor for development of MTS or any one of its components, including hypertension, central obesity, dyslipidemia, or elevated glycated hemoglobin.

The results revealed that 79.6% of the women had undergone menopause. The prevalence of MTS was higher (38.2%) among postmenopausal women, compared to 23.2% in premenopausal women. After adjusting for age, body mass index (BMI), and other covariates, menopausal women had a significantly higher relative risk of MTS, when using criteria with a lower waist circumference. Menopause was also associated with a higher risk of impaired glucose tolerance, elevated blood pressure, and elevated triglycerides. The study was published on June 29, 2020, in Menopause.

“These results reaffirm the previously identified link between menopause and metabolic syndrome,” said Stephanie Faubion, MD, medical director of The North American Menopause Society (Pepper Pike, OH, USA), who was not involved in the study. “Given the increased cardiovascular risk associated with metabolic syndrome and that heart disease remains the number one killer of women, this study highlights the importance of cardiovascular risk assessment and risk reduction strategies in midlife women.”

Menopause describes the permanent cessation of the primary functions of the human ovaries, including the cessation of estradiol and progesterone endocrine hormone production. The menopausal transition can be divided into three stages. During pre-menopause, the menstrual cycle becomes irregular; this stage begins 5-10 years before menopause. Perimenopause is the transition period prior to menopause, when the function of the ovaries noticeably fades away, leading to cessation of menstruation. Post-menopause is the time after the last menstruation.

Related Links:
St. Michael’s Hospital
University of Toronto



Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Oxidized Zirconium Implant Material
OXINIUM

Latest Patient Care News

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput